Home > Insider Trading > Filing (0001209191-20-029858)

Filing Details

Accession Number:: 0001209191-20-029858
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-15 19:11:59
Reporting Period:: 2020-05-13

Accepted Time:: 2020-05-15 19:11:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070494	Acadia Pharmaceuticals Inc	ACAD	Pharmaceutical Preparations (2834)	061376651

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1131146	Stephen Davis	C/O Acadia Pharmaceuticals Inc. 3611 Valley Centre Drive, Ste. 300 San Diego CA 92130	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-13	111,458	$19.65	123,267	No	4	M	Direct
Common Stock	Disposition	2020-05-13	13,908	$48.98	109,359	No	4	S	Direct
Common Stock	Disposition	2020-05-13	5,205	$48.60	104,154	No	4	S	Direct
Common Stock	Disposition	2020-05-13	20,756	$46.43	83,398	No	4	S	Direct
Common Stock	Disposition	2020-05-13	63,392	$45.71	20,006	No	4	S	Direct
Common Stock	Disposition	2020-05-13	8,197	$45.12	11,809	No	4	S	Direct
Common Stock	Acquisiton	2020-05-14	88,542	$19.65	100,351	No	4	M	Direct
Common Stock	Disposition	2020-05-14	84,221	$45.65	16,130	No	4	S	Direct
Common Stock	Disposition	2020-05-14	4,321	$45.01	11,809	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-13	111,458	$0.00	111,458	$19.65
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-14	88,542	$0.00	88,542	$19.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
188,542		2026-03-14	No	4	M	Direct
100,000		2026-03-14	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.73 to 49.72, inclusive.
The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.50 to $48.72, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.16 to $47.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.16 to $46.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.04 to $45.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.05 to $46.04, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.04, inclusive.
The stock option is fully vested and exercisable.